Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis

被引:132
作者
Chang, Katherine C.
Unsinger, Jacqueline
Davis, Christopher G.
Schwulst, Steven J.
Muenzer, Jared T.
Strasser, Andreas
Hotchkiss, Richard S.
机构
[1] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[5] Walter & Eliza Hall Inst Med Res, Dept Immunol, Melbourne, Vic 3050, Australia
关键词
endotoxin; necrosis; cytokines;
D O I
10.1096/fj.06-6805com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lymphocyte apoptosis plays a central role in the pathophysiology of sepsis. Lymphocyte apoptosis was examined in mice with defective death receptor pathways due to transgenic expression of a dominant negative mutant of Fas-associated death domain (FADD-DN) or Bid(-/-) and in mice with defective mitochondrial-mediated pathways due to loss of Bim(-/-), Puma(-/-), or Noxa(-/-). FADD-DN transgenic and Bid(-/-) mice had significant albeit incomplete protection, and this protection was associated with increased survival. Surprisingly, splenic B cells were also protected in FADD-DN mice although transgene expression was confined to T cells, providing evidence for an indirect protective mechanism. Bim(-/-) provided virtually complete protection against lymphocyte apoptosis whereas Puma(-/-) and Noxa(-/-) mice had modest or no protection, respectively. Bim(-/-) mice had improved survival, and adoptive transfer of splenocytes from Bim(-/-) mice into Rag 1(-/-) mice demonstrated that this was a lymphocyte intrinsic effect. The improved survival was associated with decreased interleukin (IL) -10 and IL-6 cytokines. Collectively, these data indicate that numerous death stimuli are generated during sepsis, and it therefore appears unlikely that blocking a single "trigger" can inhibit apoptosis. If siRNA becomes practical therapeutically, proapoptotic proteins would be potential targets.
引用
收藏
页码:708 / 719
页数:12
相关论文
共 60 条
[41]   Apoptosis in sepsis: a new target for therapeutic exploration [J].
Oberholzer, C ;
Oberholzer, A ;
Clare-Salzler, M ;
Moldawer, LL .
FASEB JOURNAL, 2001, 15 (06) :879-892
[42]   Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis [J].
Oberholzer, C ;
Oberholzer, A ;
Bahjat, FR ;
Minter, RM ;
Tannahill, CL ;
Abouhamze, A ;
LaFace, D ;
Hutchins, B ;
Clare-Salzler, MJ ;
Moldawer, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11503-11508
[43]   Apoptosis in the development and maintenance of the immune system [J].
Opferman, JT ;
Korsmeyer, SJ .
NATURE IMMUNOLOGY, 2003, 4 (05) :410-415
[44]   Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim [J].
Pellegrini, M ;
Belz, G ;
Bouillet, P ;
Strasser, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14175-14180
[45]   Keeping killers on a tight leash: transcriptional and posttranslational control of the pro-apoptotic activity of BH3-only proteins [J].
Puthalakath, H ;
Strasser, A .
CELL DEATH AND DIFFERENTIATION, 2002, 9 (05) :505-512
[46]   The in vivo balance between B cell clonal expansion and elimination is regulated by CD95 both on B cells and in their micro-environment [J].
Rathmell, JC ;
Goodnow, CC .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (05) :387-394
[47]   Six at six: Interleukin-6 measured 6 H after the initiation of sepsis predicts mortality over 3 days [J].
Remick, DG ;
Bolgos, GR ;
Siddiqui, J ;
Shin, J ;
Nemzek, JA .
SHOCK, 2002, 17 (06) :463-467
[48]   Cross-talk in cell death signaling [J].
Roy, S ;
Nicholson, DW .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08) :F21-F25
[49]   The role of BH3-only proteins in the immune system [J].
Strasser, A .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (03) :189-200
[50]  
Su X, 1998, J IMMUNOL, V160, P5288